BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35961298)

  • 1. Optimising multi-target multileaf collimator tracking using real-time dose for locally advanced prostate cancer patients.
    Hewson EA; Nguyen DT; Le A; Booth JT; Keall PJ; Mejnertsen L
    Phys Med Biol; 2022 Sep; 67(18):. PubMed ID: 35961298
    [No Abstract]   [Full Text] [Related]  

  • 2. Adapting to the motion of multiple independent targets using multileaf collimator tracking for locally advanced prostate cancer: Proof of principle simulation study.
    Hewson EA; Ge Y; O'Brien R; Roderick S; Bell L; Poulsen PR; Eade T; Booth JT; Keall PJ; Nguyen DT
    Med Phys; 2021 Jan; 48(1):114-124. PubMed ID: 33124079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First experimental evaluation of multi-target multileaf collimator tracking during volumetric modulated arc therapy for locally advanced prostate cancer.
    Hewson EA; Dipuglia A; Kipritidis J; Ge Y; O'Brien R; Roderick S; Bell L; Poulsen PR; Eade T; Booth JT; Keall PJ; Nguyen DT
    Radiother Oncol; 2021 Jul; 160():212-220. PubMed ID: 33971194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental investigation of dynamic real-time rotation-including dose reconstruction during prostate tracking radiotherapy.
    Muurholm CG; Ravkilde T; De Roover R; Skouboe S; Hansen R; Crijns W; Depuydt T; Poulsen PR
    Med Phys; 2022 Jun; 49(6):3574-3584. PubMed ID: 35395104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-based optimisation for multi-leaf collimator tracking during radiation therapy.
    Mejnertsen L; Hewson E; Nguyen DT; Booth J; Keall P
    Phys Med Biol; 2021 Mar; 66(6):065027. PubMed ID: 33607648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electromagnetic guided couch and multileaf collimator tracking on a TrueBeam accelerator.
    Hansen R; Ravkilde T; Worm ES; Toftegaard J; Grau C; Macek K; Poulsen PR
    Med Phys; 2016 May; 43(5):2387. PubMed ID: 27147350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential benefits of dosimetric VMAT tracking verified with 3D film measurements.
    Crijns W; Defraene G; Van Herck H; Depuydt T; Haustermans K; Maes F; Van den Heuvel F
    Med Phys; 2016 May; 43(5):2162. PubMed ID: 27147328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-resolved dose distributions to moving targets during volumetric modulated arc therapy with and without dynamic MLC tracking.
    Ravkilde T; Keall PJ; Grau C; Høyer M; Poulsen PR
    Med Phys; 2013 Nov; 40(11):111723. PubMed ID: 24320431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Volumetric modulated arc therapy with dynamic collimator rotation for improved multileaf collimator tracking of the prostate.
    Murtaza G; Toftegaard J; Khan EU; Poulsen PR
    Radiother Oncol; 2017 Jan; 122(1):109-115. PubMed ID: 27908453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fast motion-including dose error reconstruction for VMAT with and without MLC tracking.
    Ravkilde T; Keall PJ; Grau C; Høyer M; Poulsen PR
    Phys Med Biol; 2014 Dec; 59(23):7279-96. PubMed ID: 25383729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential improvements of lung and prostate MLC tracking investigated by treatment simulations.
    Toftegaard J; Keall PJ; O'Brien R; Ruan D; Ernst F; Homma N; Ichiji K; Poulsen PR
    Med Phys; 2018 May; 45(5):2218-2229. PubMed ID: 29574859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of leaf width and plan complexity on DMLC tracking of prostate intensity modulated arc therapy.
    Pommer T; Falk M; Poulsen PR; Keall PJ; O'Brien RT; Munck af Rosenschöld P
    Med Phys; 2013 Nov; 40(11):111717. PubMed ID: 24320425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DMLC tracking and gating can improve dose coverage for prostate VMAT.
    Colvill E; Poulsen PR; Booth JT; O'Brien RT; Ng JA; Keall PJ
    Med Phys; 2014 Sep; 41(9):091705. PubMed ID: 25186380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simulated multileaf collimator tracking for stereotactic liver radiotherapy guided by kilovoltage intrafraction monitoring: Dosimetric gain and target overdose trends.
    Poulsen PR; Murtaza G; Worm ES; Ravkilde T; O'Brien R; Grau C; Høyer M; Keall P
    Radiother Oncol; 2020 Mar; 144():93-100. PubMed ID: 31786423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-time motion-including dose estimation of simulated multi-leaf collimator-tracked magnetic resonance-guided radiotherapy.
    Persson E; Goodwin E; Eiben B; Wetscherek A; Nill S; Oelfke U
    Med Phys; 2024 Mar; 51(3):2221-2229. PubMed ID: 37898109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric impact of intrafraction prostate rotation and accuracy of gating, multi-leaf collimator tracking and couch tracking to manage rotation: An end-to-end validation using volumetric film measurements.
    De Roover R; Hansen R; Crijns W; Muurholm CG; Poels K; Skouboe S; Haustermans K; Poulsen PR; Depuydt T
    Radiother Oncol; 2021 Mar; 156():10-18. PubMed ID: 33264640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric benefit of DMLC tracking for conventional and sub-volume boosted prostate intensity-modulated arc radiotherapy.
    Pommer T; Falk M; Poulsen PR; Keall PJ; O'Brien RT; Petersen PM; Munck af Rosenschöld P
    Phys Med Biol; 2013 Apr; 58(7):2349-61. PubMed ID: 23492899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward real-time verification for MLC tracking treatments using time-resolved EPID imaging.
    Zwan BJ; Caillet V; Booth JT; Colvill E; Fuangrod T; O'Brien R; Briggs A; O'Connor DJ; Keall PJ; Greer PB
    Med Phys; 2021 Mar; 48(3):953-964. PubMed ID: 33354787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Couch and multileaf collimator tracking: A clinical feasibility study for pancreas and liver treatment.
    Zhang L; LoSasso T; Zhang P; Hunt M; Mageras G; Tang G
    Med Phys; 2020 Oct; 47(10):4743-4757. PubMed ID: 32757298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is multileaf collimator tracking or gating a better intrafraction motion adaptation strategy? An analysis of the TROG 15.01 stereotactic prostate ablative radiotherapy with KIM (SPARK) trial.
    Hewson EA; Nguyen DT; O'Brien R; Poulsen PR; Booth JT; Greer P; Eade T; Kneebone A; Hruby G; Moodie T; Hayden AJ; Turner SL; Hardcastle N; Siva S; Tai KH; Martin J; Keall PJ
    Radiother Oncol; 2020 Oct; 151():234-241. PubMed ID: 32828839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.